| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70381 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70382 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70407 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-22436-100ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76843-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70378 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-52437-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61748-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-37287-0.025ml | |||
![Immunohistochemistry: CD68/SR-D1 Antibody (OTI1E6) [NBP2-46168] - CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Human lymph node tissue.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Immunohistochemistry-NBP2-46168-img0010.jpg "Immunohistochemistry: CD68/SR-D1 Antibody (OTI1E6) [NBP2-46168] - CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Human lymph node tissue.")
![Immunohistochemistry: CD68/SR-D1 Antibody (OTI1E6) [NBP2-46168] - CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Human lymphoma tissue.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Immunohistochemistry-NBP2-46168-img0011.jpg)
![Western Blot: CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD68.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Western-Blot-NBP2-46168-img0013.jpg)
![Immunohistochemistry: CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Human tonsil tissue.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Immunohistochemistry-NBP2-46168-img0012.jpg)
![Immunohistochemistry: CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Adenocarcinoma of Human breast tissue.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Immunohistochemistry-NBP2-46168-img0001.jpg)
![Immunohistochemistry: CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Adenocarcinoma of Human colon tissue.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Immunohistochemistry-NBP2-46168-img0002.jpg)
![Immunohistochemistry: CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Human Kidney tissue.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Immunohistochemistry-NBP2-46168-img0003.jpg)
![Immunohistochemistry: CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Carcinoma of Human kidney tissue.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Immunohistochemistry-NBP2-46168-img0004.jpg)
![Immunohistochemistry: CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Human liver tissue.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Immunohistochemistry-NBP2-46168-img0005.jpg)
![Immunohistochemistry: CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Carcinoma of Human lung tissue.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Immunohistochemistry-NBP2-46168-img0006.jpg)
![Immunohistochemistry: CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Adenocarcinoma of Human ovary tissue.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Immunohistochemistry-NBP2-46168-img0007.jpg)
![Immunohistochemistry: CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Carcinoma of Human pancreas tissue.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Immunohistochemistry-NBP2-46168-img0008.jpg)
![Immunohistochemistry: CD68/SR-D1 Antibody (1E6) [NBP2-46168] - Analysis of Human bladder tissue.](http://images.novusbio.com/fullsize/CD68-SR-D1-Antibody-1E6-Immunohistochemistry-NBP2-46168-img0009.jpg)
![Western Blot: CD74 Antibody (1H3) [NBP2-46179] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD74.](http://images.novusbio.com/fullsize/CD74-Antibody-1H3-Western-Blot-NBP2-46179-img0008.jpg "Western Blot: CD74 Antibody (1H3) [NBP2-46179] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD74.")
![Immunohistochemistry: CD74 Antibody (1H3) [NBP2-46179] - Analysis of Human lymphoma tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CD74-Antibody-1H3-Immunohistochemistry-NBP2-46179-img0007.jpg)
![Immunohistochemistry: CD74 Antibody (1H3) [NBP2-46179] - Analysis of Human Kidney tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CD74-Antibody-1H3-Immunohistochemistry-NBP2-46179-img0001.jpg)
![Immunohistochemistry: CD74 Antibody (1H3) [NBP2-46179] - Analysis of Adenocarcinoma of Human ovary tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CD74-Antibody-1H3-Immunohistochemistry-NBP2-46179-img0002.jpg)
![Immunohistochemistry: CD74 Antibody (1H3) [NBP2-46179] - Analysis of Human endometrium tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CD74-Antibody-1H3-Immunohistochemistry-NBP2-46179-img0003.jpg)
![Immunohistochemistry: CD74 Antibody (1H3) [NBP2-46179] - Analysis of Adenocarcinoma of Human endometrium tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CD74-Antibody-1H3-Immunohistochemistry-NBP2-46179-img0004.jpg)
![Immunohistochemistry: CD74 Antibody (1H3) [NBP2-46179] - Analysis of Carcinoma of Human bladder tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CD74-Antibody-1H3-Immunohistochemistry-NBP2-46179-img0005.jpg)
![Immunohistochemistry: CD74 Antibody (1H3) [NBP2-46179] - Analysis of Human lymph node tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CD74-Antibody-1H3-Immunohistochemistry-NBP2-46179-img0006.jpg)
![Western Blot: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CEACAM-5.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Western-Blot-NBP2-46231-img0018.jpg "Western Blot: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CEACAM-5.")
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human tonsil tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0017.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human colon tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0001.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human Kidney tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0002.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human liver tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0003.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Carcinoma of Human liver tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0004.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human lung tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0005.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Carcinoma of Human lung tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0006.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Adenocarcinoma of Human ovary tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0007.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human pancreas tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0008.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Carcinoma of Human pancreas tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0009.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human endometrium tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0010.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human prostate tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0011.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Carcinoma of Human prostate tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0012.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human bladder tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0013.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Carcinoma of Human bladder tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0014.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human lymph node tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0015.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human lymphoma tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0016.jpg)
![Immunocytochemistry/Immunofluorescence: CD44 Antibody (1M7.8.1) [NBP2-22436] - Analysis of CD44 (green) showing staining in the membrane of BAF-3 cells (right) compared to a negative control without primary antibody (left).](http://images.novusbio.com/fullsize/CD44-Antibody-1M7-8-1-Immunocytochemistry-Immunofluorescence-NBP2-22436-img0004.jpg "Immunocytochemistry/Immunofluorescence: CD44 Antibody (1M7.8.1) [NBP2-22436] - Analysis of CD44 (green) showing staining in the membrane of BAF-3 cells (right) compared to a negative control without primary antibody (left).")
![Flow Cytometry: CD44 Antibody (1M7.8.1) [NBP2-22436] - Analysis of CD44 in Hela cells (green) compared to an isotype control (blue).](http://images.novusbio.com/fullsize/CD44-Antibody-1M7-8-1-Flow-Cytometry-NBP2-22436-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: CD44 Antibody (1M7.8.1) [NBP2-22436] - Analysis of CD44 (green) showing staining in the membrane of Hela cells (right) compared to a negative control without primary antibody (left).](http://images.novusbio.com/fullsize/CD44-Antibody-1M7-8-1-Immunocytochemistry-Immunofluorescence-NBP2-22436-img0003.jpg)
![Immunocytochemistry/Immunofluorescence: CD44 Antibody (1M7.8.1) [NBP2-22436] - Analysis of CD44 (green) showing staining in the membrane and cytoplasm of NIH-3T3 cells (right) compared to a negative control without primary antibody (left).](http://images.novusbio.com/fullsize/CD44-Antibody-1M7-8-1-Immunocytochemistry-Immunofluorescence-NBP2-22436-img0005.jpg)
![Flow Cytometry: CD44 Antibody (1M7.8.1) [NBP2-22436] - Analysis of CD44 in mouse splenocytes (green) compared to an isotype control (blue).](http://images.novusbio.com/fullsize/CD44-Antibody-1M7-8-1-Flow-Cytometry-NBP2-22436-img0001.jpg)
![Western Blot: BAFF/BLyS/TNFSF13B Antibody [NBP1-76843] - Western Blot Validation with Recombinant Protein. Loading: 30 ng of human BAFF recombinant protein per lane. Antibodies: BAFF/BLyS/TNFSF13B NBP1-76843 (Lane 1: 0.25 ug/mL; Lane 2: 0.5 ug/mL and Lane 3: 1 ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. Observed at around 18kDa.](http://images.novusbio.com/fullsize/BAFF-BLyS-TNFSF13B-Antibody-Western-Blot-NBP1-76843-img0005.jpg "<b>Expression of Tagged Proteins Validation. </b>Western Blot: BAFF/BLyS/TNFSF13B Antibody [NBP1-76843] - Western Blot Validation with Recombinant Protein. Loading: 30 ng of human BAFF recombinant protein per lane. Antibodies: BAFF/BLyS/TNFSF13B NBP1-76843 (Lane 1: 0.25 ug/mL; Lane 2: 0.5 ug/mL and Lane 3: 1 ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. Observed at around 18kDa.")
![<b>Expression of Tagged Proteins Validation. </b>Western Blot: BAFF/BLyS/TNFSF13B Antibody [NBP1-76843] - Western Blot Validation in Human, Mouse and Rat Cell Lines. Loading: 15 ug of lysates per lane. Antibodies: BAFF/BLyS/TNFSF13B NBP1-76843 (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/BAFF-BLyS-TNFSF13B-Antibody-Western-Blot-NBP1-76843-img0004.jpg)
![Immunocytochemistry/ Immunofluorescence: BAFF/BLyS/TNFSF13B Antibody - BSA Free [NBP1-76843] - Validation of BAFF/BLyS/TNFSF13B in HL60 Cells. Immunocytochemical analysis of HL60 cells using anti-BAFF/BLyS/TNFSF13B antibody at 1 ug/ml. Cells was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.](http://images.novusbio.com/fullsize/nbp1-76843_rabbit-polyclonal-baff-blys-tnfsf13b-antibody-271120242010580.jpg)
![Western Blot: BAFF/BLyS/TNFSF13B Antibody - BSA Free [NBP1-76843] - Validation in Human HL60 Cell Lysate (H) and Mouse Spleen Lysate (M). Loading: 15 ug of lysates per lane.Antibodies: BAFF/BLyS/TNFSF13B (1 u/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/nbp1-76843_rabbit-polyclonal-baff-blys-tnfsf13b-antibody-2711202420285892.jpg)
![Immunocytochemistry/ Immunofluorescence: BAFF/BLyS/TNFSF13B Antibody - BSA Free [NBP1-76843] - Validation of BAFF/BLyS/TNFSF13B in Human Spleen Tissue. Immunofluorescent analysis of 4% paraformaldehyde-fixed human spleen tissue labeling BAFF/BLyS/TNFSF13B with at 20 ug/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue).](http://images.novusbio.com/fullsize/nbp1-76843_rabbit-polyclonal-baff-blys-tnfsf13b-antibody-2711202420285848.gif)
![Western Blot: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD40.](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Western-Blot-NBP2-46150-img0013.jpg "Western Blot: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD40.")
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Human tonsil tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0012.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Human breast tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0001.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Adenocarcinoma of Human breast tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0002.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Human colon tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0003.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Human Kidney tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0004.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Carcinoma of Human kidney tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0005.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Carcinoma of Human liver tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0006.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Adenocarcinoma of Human ovary tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0007.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Human pancreas tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0008.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Adenocarcinoma of Human endometrium tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0009.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Carcinoma of Human prostate tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0010.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (8B8) [NBP2-46150] - Analysis of Human lymphoma tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-8B8-Immunohistochemistry-NBP2-46150-img0011.jpg)
![Immunocytochemistry/Immunofluorescence: Clusterin/APOJ Antibody [NBP1-06027] - Immunofluorescence analysis of paraformaldehyde fixed PC12 suspension cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml), showing membrane and cytoplasmic staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml).](http://images.novusbio.com/fullsize/nbp1-06027_goat-polyclonal-clusterin-apoj-antibody-16520239183316.jpg "Immunocytochemistry/Immunofluorescence: Clusterin/APOJ Antibody [NBP1-06027] - Immunofluorescence analysis of paraformaldehyde fixed PC12 suspension cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml), showing membrane and cytoplasmic staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml).")
![Western Blot: Clusterin/APOJ Antibody [NBP1-06027] - (0.1ug/ml) staining of Mouse (A) and (0.3ug/ml) Rat (B) Brain lysate (35ug protein in RIPA buffer). Detected by chemiluminescence.](http://images.novusbio.com/fullsize/nbp1-06027_goat-polyclonal-clusterin-apoj-antibody-1652023918330.jpg)
![Immunocytochemistry/Immunofluorescence: ATR [p Ser428] Antibody [NBP3-05447] - Immunofluorescence analysis of U2OS cells using ATR antibody (NBP3-05447) at dilution of 1:100. Blue: DAPI for nuclear staining.](http://images.novusbio.com/fullsize/ATR-[p-Ser428]-Antibody-Immunocytochemistry-Immunofluorescence-NBP3-05447-img0001.jpg "Immunocytochemistry/Immunofluorescence: ATR [p Ser428] Antibody [NBP3-05447] - Immunofluorescence analysis of U2OS cells using ATR antibody (NBP3-05447) at dilution of 1:100. Blue: DAPI for nuclear staining.")
![Immunohistochemistry-Paraffin: ATR [p Ser428] Antibody [NBP3-05447] - Rat testis using ATR Rabbit pAb (NBP3-05447) at dilution of 1:100 (40x lens). Perform high pressure antigen retrieval with 10 mM citrate buffer pH 6.0 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/ATR-[p-Ser428]-Antibody-Immunohistochemistry-Paraffin-NBP3-05447-img0005.jpg)
![Immunohistochemistry-Paraffin: ATR [p Ser428] Antibody [NBP3-05447] - Human testis using ATR Rabbit pAb (NBP3-05447) at dilution of 1:100 (40x lens). Perform high pressure antigen retrieval with 10 mM citrate buffer pH 6.0 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/ATR-[p-Ser428]-Antibody-Immunohistochemistry-Paraffin-NBP3-05447-img0003.jpg)
![Immunohistochemistry-Paraffin: ATR [p Ser428] Antibody [NBP3-05447] - Mouse testis using ATR Rabbit pAb (NBP3-05447) at dilution of 1:100 (40x lens). Perform high pressure antigen retrieval with 10 mM citrate buffer pH 6.0 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/ATR-[p-Ser428]-Antibody-Immunohistochemistry-Paraffin-NBP3-05447-img0004.jpg)
![Western Blot: ATR [p Ser428] Antibody [NBP3-05447] - Analysis of 293T, using Phospho-ATR-S428 antibody at 1:400 dilution.293T cells were treated by UV at room temperature for 15-30 minutes. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 90s.](http://images.novusbio.com/fullsize/antibody/nbp3-05447_rabbit-polyclonal-atr-p-ser428-antibody-western-blot-265202385445.jpg)
![Western Blot: ATR [p Ser428] Antibody [NBP3-05447] - Analysis of NIH/3T3, using Phospho-ATR-S428 antibody at 1:400 dilution.NIH/3T3 cells were treated by Nocodazole (50 ng/ml) at 37 for 20 hours.Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 90s.](http://images.novusbio.com/fullsize/antibody/nbp3-05447_rabbit-polyclonal-atr-p-ser428-antibody-western-blot-265202385627.jpg)
![Western Blot: CD44 Antibody (9W6E7) [CD44] - Western blot analysis of various lysates using CD44 Rabbit mAb at 1:20000 dilution incubated overnight at 4C.Secondary antibody: HRP-conjugated Goat anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25 ug per lane.Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Basic Kit .Exposure time: 45s.](http://images.novusbio.com/fullsize/nbp3-15617_rabbit-cd44-mab-9w6e7-5220251734544.jpg "Western Blot: CD44 Antibody (9W6E7) [CD44] - Western blot analysis of various lysates using CD44 Rabbit mAb at 1:20000 dilution incubated overnight at 4C.Secondary antibody: HRP-conjugated Goat anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25 ug per lane.Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Basic Kit .Exposure time: 45s.")
![Immunohistochemistry: CD44 Antibody (9W6E7) [CD44] - Immunohistochemistry analysis of paraffin-embedded Human liver cancer using CD44 Rabbit mAb at dilution of 1:2000 (40x lens). High pressure antigen retrieval performed with 0.01M Tris/EDTA Buffer (pH 9.0) prior to IHC staining.](http://images.novusbio.com/fullsize/nbp3-15617_rabbit-cd44-mab-9w6e7-52202517315598.jpg)
![Immunohistochemistry: CD44 Antibody (9W6E7) [CD44] - Immunohistochemistry analysis of paraffin-embedded Human skin using CD44 Rabbit mAb at dilution of 1:2000 (40x lens). High pressure antigen retrieval performed with 0.01M Tris/EDTA Buffer (pH 9.0) prior to IHC staining.](http://images.novusbio.com/fullsize/nbp3-15617_rabbit-cd44-mab-9w6e7-52202517344236.jpg)
![Immunocytochemistry/ Immunofluorescence: CD44 Antibody (9W6E7) [CD44] - Confocal imaging of HeLa cells using CD44 Rabbit mAb followed by a further incubation with Cy3 Goat Anti-Rabbit IgG (H+L) . The cells were counterstained with alpha-Tubulin Mouse mAb followed by incubation with ABflo 488-conjugated Goat Anti-Mouse IgG (H+L) Ab (Green). DAPI was used for nuclear staining (Blue). Objective: 100x.](http://images.novusbio.com/fullsize/nbp3-15617_rabbit-cd44-mab-9w6e7-52202517352722.jpg)
![Flow Cytometry: CD44 Antibody (9W6E7) [CD44] - Flow cytometry: 1X10^6 Jurkat cells (negative control,left) and HeLa cells were surface-stained with CD44 Rabbit mAb or ABflo 647 Rabbit IgG isotype control , followed by Alexa Fluor 647 conjugated goat anti-rabbit pAb staining. Non-fluorescently stained cells were used as blank control .](http://images.novusbio.com/fullsize/nbp3-15617_rabbit-cd44-mab-9w6e7-5220251735270.jpg)
![Flow Cytometry: CD44 Antibody (9W6E7) [CD44] - Flow cytometry: 1X10^6 HeLa cells were surface-stained with ABflo 647 Rabbit IgG isotype control or CD44 Rabbit mAb .](http://images.novusbio.com/fullsize/nbp3-15617_rabbit-cd44-mab-9w6e7-52202517304969.jpg)
![Western Blot: RHAMM/CD168 Antibody (2F2C9) [NBP2-52437] - Analysis using CD168 mAb against HEK293 (1) and CD168 (AA: 306-497)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/RHAMM-CD168-Antibody-2F2C9-Western-Blot-NBP2-52437-img0003.jpg "Western Blot: RHAMM/CD168 Antibody (2F2C9) [NBP2-52437] - Analysis using CD168 mAb against HEK293 (1) and CD168 (AA: 306-497)-hIgGFc transfected HEK293 (2) cell lysate.")
![Flow Cytometry: RHAMM/CD168 Antibody (2F2C9) [NBP2-52437] - An intracellular stain was performed on Jurkat cells with RHAMM/CD168 Antibody (2F2C9) NBP2-52437AF488 and a matched isotype control. Cells were fixed with 4% PFA and then permeablized with 0.1% saponin. Cells were incubated in an antibody dilution of 10 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to Alexa Fluor 488.](http://images.novusbio.com/fullsize/RHAMM-CD168-Antibody-2F2C9-Flow-Cytometry-NBP2-52437-img0007.jpg)
![Western Blot: RHAMM/CD168 Antibody (2F2C9) [NBP2-52437] - Analysis using CD168 mAb against human CD168 (AA: 306-497) recombinant protein. (Expected MW is 48.3 kDa)](http://images.novusbio.com/fullsize/RHAMM-CD168-Antibody-2F2C9-Western-Blot-NBP2-52437-img0002.jpg)
![Flow Cytometry: RHAMM/CD168 Antibody (2F2C9) [NBP2-52437] - Analysis of Hela cells using CD168 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/RHAMM-CD168-Antibody-2F2C9-Flow-Cytometry-NBP2-52437-img0001.jpg)
![Flow Cytometry: RHAMM/CD168 Antibody (2F2C9) [NBP2-52437] - An intracellular stain was performed on A549 cells with RHAMM/CD168 Antibody (2F2C9) NBP2-52437PE and a matched isotype control. Cells were fixed with 4% PFA and then permeablized with 0.1% saponin. Cells were incubated in an antibody dilution of 2.5 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to Phycoerythrin.](http://images.novusbio.com/fullsize/RHAMM-CD168-Antibody-2F2C9-Flow-Cytometry-NBP2-52437-img0005.jpg)
![Flow Cytometry: RHAMM/CD168 Antibody (2F2C9) [NBP2-52437] - An intracellular stain was performed on Jurkat cells with RHAMM/CD168 Antibody (2F2C9) NBP2-52437PE and a matched isotype control. Cells were fixed with 4% PFA and then permeablized with 0.1% saponin. Cells were incubated in an antibody dilution of 2.5 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to Phycoerythrin.](http://images.novusbio.com/fullsize/RHAMM-CD168-Antibody-2F2C9-Flow-Cytometry-NBP2-52437-img0006.jpg)
![ELISA: RHAMM/CD168 Antibody (2F2C9) [NBP2-52437] - Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);](http://images.novusbio.com/fullsize/RHAMM-CD168-Antibody-2F2C9-ELISA-NBP2-52437-img0004.jpg)
![Western Blot: P2X7/P2RX7 Antibody (7G1D6) [NBP2-61748] - Analysis using P2RX7 mAb against HEK293 (1) and P2RX7 (AA: 226-452)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/P2X7-P2RX7-Antibody-7G1D6-Western-Blot-NBP2-61748-img0005.jpg "Western Blot: P2X7/P2RX7 Antibody (7G1D6) [NBP2-61748] - Analysis using P2RX7 mAb against HEK293 (1) and P2RX7 (AA: 226-452)-hIgGFc transfected HEK293 (2) cell lysate.")
![Immunohistochemistry-Paraffin: P2X7/P2RX7 Antibody (7G1D6) [NBP2-61748] - Analysis of esophageal cancer tissues using P2RX7 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/P2X7-P2RX7-Antibody-7G1D6-Immunohistochemistry-NBP2-61748-img0003.jpg)
![Flow Cytometry: P2X7/P2RX7 Antibody (7G1D6) [NBP2-61748] - Analysis of Hela cells using P2RX7 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/P2X7-P2RX7-Antibody-7G1D6-Flow-Cytometry-NBP2-61748-img0002.jpg)
![Western Blot: P2X7/P2RX7 Antibody (7G1D6) [NBP2-61748] - Analysis using P2RX7 mAb against human P2RX7 (AA: 226-452) recombinant protein. (Expected MW is 48.9 kDa)](http://images.novusbio.com/fullsize/P2X7-P2RX7-Antibody-7G1D6-Western-Blot-NBP2-61748-img0004.jpg)
![Western Blot: P2X7/P2RX7 Antibody (7G1D6) [NBP2-61748] - Analysis using P2RX7 mouse mAb against A431 (1), U251 (2), Hela (3), U937 (4), and HepG2 (5) cell lysate.](http://images.novusbio.com/fullsize/P2X7-P2RX7-Antibody-7G1D6-Western-Blot-NBP2-61748-img0006.jpg)
![ELISA: P2X7/P2RX7 Antibody (7G1D6) [NBP2-61748] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/P2X7-P2RX7-Antibody-7G1D6-ELISA-NBP2-61748-img0001.jpg)
![Western Blot: beta 2-Microglobulin Antibody (3G5H8) [NBP2-37287] - Western blot analysis using B2M mouse mAb against Hela (1), HEK293 (2), HepG2 (3),RAJI (4), A431 (5) and Jurkat (6) cell lysate.](http://images.novusbio.com/fullsize/beta-2-Microglobulin-Antibody-3G5H8-Western-Blot-NBP2-37287-img0004.jpg "Western Blot: beta 2-Microglobulin Antibody (3G5H8) [NBP2-37287] - Western blot analysis using B2M mouse mAb against Hela (1), HEK293 (2), HepG2 (3),RAJI (4), A431 (5) and Jurkat (6) cell lysate.")
![Immunohistochemistry: beta 2-Microglobulin Antibody (3G5H8) [NBP2-37287] - Immunohistochemical analysis of paraffin-embedded esophageal cancer tissues using B2M mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/beta-2-Microglobulin-Antibody-3G5H8-Immunohistochemistry-NBP2-37287-img0007.jpg)
![Flow Cytometry: beta 2-Microglobulin Antibody (3G5H8) [NBP2-37287] - Flow cytometric analysis of A431 cells using B2M mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/beta-2-Microglobulin-Antibody-3G5H8-Flow-Cytometry-NBP2-37287-img0005.jpg)
![Western Blot: beta 2-Microglobulin Antibody (3G5H8) [NBP2-37287] - Western blot analysis using B2M mAb against human B2M (AA: 21-100) recombinant protein. (Expected MW is 35.4 kDa)](http://images.novusbio.com/fullsize/beta-2-Microglobulin-Antibody-3G5H8-Western-Blot-NBP2-37287-img0002.jpg)
![Western Blot: beta 2-Microglobulin Antibody (3G5H8) [NBP2-37287] - Western blot analysis using B2M mAb against HEK293 (1) and B2M (AA: 21-100)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/beta-2-Microglobulin-Antibody-3G5H8-Western-Blot-NBP2-37287-img0003.jpg)
![Immunohistochemistry: beta 2-Microglobulin Antibody (3G5H8) [NBP2-37287] - Immunohistochemical analysis of paraffin-embedded ovarian cancer tissues using B2M mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/beta-2-Microglobulin-Antibody-3G5H8-Immunohistochemistry-NBP2-37287-img0006.jpg)
![ELISA: beta 2-Microglobulin Antibody (3G5H8) [NBP2-37287] - Red: Control Antigen (100ng); Purple: Antigen (10ng); Green: Antigen (50ng); Blue: Antigen (100ng);](http://images.novusbio.com/fullsize/beta-2-Microglobulin-Antibody-3G5H8-ELISA-NBP2-37287-img0001.jpg)